zuChem Announces Appointment of Jeffrey Whitnell as Chief Financial Officer

Chicago, IL (May 27, 2015) – zuChem, Inc., an innovative supplier of glycochemicals and specialized sugars for the food ingredients, fine chemicals and related industries, today announced the appointment of Jeffrey A. Whitnell as Chief Financial Officer (CFO).

In his role at zuChem Mr. Whitnell will oversee the company’s finance operations and be part of the zuChem executive team, reporting to CEO David Demirjian, Ph.D.

Commenting, David Demirjian said, “I am pleased to welcome Jeff Whitnell as CFO. In his prior positions in the life sciences industry, Jeff has proven himself a key member of leadership teams. His extensive, on-point experience will provide critical strategic oversight as we expand our commercial operations.”

Mr. Whitnell brings more than fifteen years of broad financial experience and leadership in the life sciences industry to his role at zuChem.  He was most recently CFO at ReliefBand Medical Technologies, a Chicago-based medical device company. Prior to ReliefBand, he served as CFO for Akorn, Inc., Vice President of Finance and Treasurer for Ovation Pharmaceuticals, and Vice President of Finance and Treasurer for MediChem Life Sciences.  He currently serves as a Director for Elite Pharmaceuticals, Inc., a publicly traded specialty pharmaceuticals company.  Mr. Whitnell holds a Bachelor of Science in Accounting from the University of Illinois at Urbana-Champaign, is a Certified Public Accountant, and earned a Master of Business Administration in Finance from The University of Chicago Booth School of Business.